Sinphar Pharmaceutical Co.,Ltd. (1734.TW)
TWD 29.1
(0.0%)
TWD 29.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.96 Billion | 2.85 Billion | 2.43 Billion | 2.38 Billion | 2.39 Billion | 2.21 Billion |
| Cost of Revenue | 1.87 Billion | 1.76 Billion | 1.54 Billion | 1.51 Billion | 1.45 Billion | 1.39 Billion |
| Gross Profit | 1.09 Billion | 1.09 Billion | 888.7 Million | 875.53 Million | 940.84 Million | 825.38 Million |
| Operating Expenses | 807.86 Million | 893.49 Million | 1.06 Billion | 999.55 Million | 1.08 Billion | 944.67 Million |
| Selling, General and Administrative Expenses | 672.6 Million | 621.33 Million | 557.06 Million | 537.16 Million | 558.78 Million | 568.3 Million |
| Research and Development Expenses | 132.58 Million | 272.16 Million | 511.88 Million | 462.39 Million | 527.8 Million | 376.37 Million |
| Other Expenses | 2.68 Million | 69.74 Million | 19.36 Million | 25.13 Million | 83.38 Million | 40.74 Million |
| Cost and Expenses | 2.67 Billion | 2.65 Billion | 2.61 Billion | 2.51 Billion | 2.54 Billion | 2.33 Billion |
| Operating Income | 286.05 Million | 273.32 Million | -157.19 Million | -95.09 Million | -62.36 Million | -119.29 Million |
| Interest Expense | 33.71 Million | 27.81 Million | 24.79 Million | 24.51 Million | 23.11 Million | 20.44 Million |
| Income Tax Expense | -51.06 Million | 80.87 Million | 20.43 Million | 54.78 Million | 61.21 Million | 35.32 Million |
| Earnings before Tax | 305.7 Million | 245.04 Million | -184.52 Million | -117.77 Million | -86.7 Million | -87.68 Million |
| Net Income | 375.17 Million | 164.17 Million | -204.95 Million | -172.55 Million | -147.92 Million | 8.78 Million |
| Earnings Per Share Basic | 2.24 | 0.98 | -1.22 | -1.03 | -0.88 | 0.05 |
| Earnings Per Share Diluted | 2.07 | 0.98 | -1.22 | -1.03 | -0.88 | 0.05 |
| Weighted Average Shares Outstanding | 167.72 Million | 167.72 Million | 167.72 Million | 167.72 Million | 167.72 Million | 167.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 181.47 Million | 168.01 Million | 167.72 Million | 167.72 Million | 167.84 Million | 167.79 Million |
| Gross Margin | 0.37 | 0.38 | 0.37 | 0.37 | 0.39 | 0.37 |
| EBIT Margin | 0.20 | 0.19 | 0.05 | 0.07 | 0.07 | 0.07 |
| Profit Margin | 0.13 | 0.06 | -0.08 | -0.07 | -0.06 | 0.00 |
| EBITDA | 582.94 Million | 539.57 Million | 109.64 Million | 157.16 Million | 173.17 Million | 171.56 Million |
| Earnings Before Tax Margin | 0.10 | 0.10 | -0.06 | -0.04 | -0.03 | -0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 769.32 Million | 777.39 Million | 2.96 Billion | 748.56 Million | 715.76 Million | 727.58 Million |
| Cost of Revenue | 490 Million | 458.87 Million | 1.87 Billion | 465.37 Million | 441.17 Million | 481.32 Million |
| Gross Profit | 279.32 Million | 318.52 Million | 1.09 Billion | 283.19 Million | 274.58 Million | 246.26 Million |
| Operating Expenses | 200.46 Million | 245.14 Million | 805.18 Million | 171.31 Million | 219.12 Million | 212.96 Million |
| Selling, General and Administrative Expenses | 163.53 Million | 204.58 Million | - | 187.27 Million | 165.15 Million | 164.14 Million |
| Research and Development Expenses | 36.92 Million | 40.56 Million | - | -15.34 Million | 53.97 Million | 48.81 Million |
| Other Expenses | 3.69 Million | -245.14 Million | -805.18 Million | -171.31 Million | 13.26 Million | 11.79 Million |
| Cost and Expenses | 690.46 Million | 704.01 Million | 2.67 Billion | 636.68 Million | 660.29 Million | 694.28 Million |
| Operating Income | 78.86 Million | 73.37 Million | 286.05 Million | 111.87 Million | 72.16 Million | 48.4 Million |
| Interest Expense | 9.2 Million | 8.89 Million | 33.71 Million | 8.98 Million | 8.21 Million | 8.21 Million |
| Income Tax Expense | 17.5 Million | -25.77 Million | -51.06 Million | -12.44 Million | -1.11 Million | -60.58 Million |
| Earnings before Tax | 78.31 Million | 78.98 Million | 305.7 Million | 110.32 Million | 63.94 Million | 37.89 Million |
| Net Income | 64.93 Million | 110.37 Million | 375.17 Million | 109.84 Million | 76.16 Million | 109.04 Million |
| Earnings Per Share Basic | 0.39 | 0.66 | - | 0.66 | 0.45 | 0.65 |
| Earnings Per Share Diluted | 0.39 | 0.66 | - | 0.66 | 0.45 | 0.65 |
| Weighted Average Shares Outstanding | 167.72 Million | 167.23 Million | 167.72 Million | 167.72 Million | 167.72 Million | 167.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 167.86 Million | 167.23 Million | 168.03 Million | 167.72 Million | 167.94 Million | 167.86 Million |
| Gross Margin | 0.36 | 0.41 | 0.37 | 0.38 | 0.38 | 0.34 |
| EBIT Margin | 0.18 | 0.19 | - | 0.24 | 0.19 | 0.15 |
| Profit Margin | 0.08 | 0.14 | 0.13 | 0.15 | 0.11 | 0.15 |
| EBITDA | 141.97 Million | 151.33 Million | - | 183.01 Million | 132.73 Million | 107.48 Million |
| Earnings Before Tax Margin | 0.10 | 0.09 | 0.10 | 0.15 | 0.10 | 0.07 |
GTK
9917
TPP
3042
8200
3680